All Stories

  1. Synthesis, crystal structure, Hirshfeld and docking studies of one-dimensional copper(II) coordination polymer incorporating adeninato, 5-methyluracilato and ammonia ligands
  2. Catalytic transesterification and photocatalytic degradation potential evaluation of waste materials based MOF@CaO composite using conventional and response surface methodology approaches
  3. Synthesis, physicochemical characterization, exploration of biological potential and DFT study of di-and tri-organotin(IV) carboxylate derivatives
  4. Synthesis, spectroscopic, computational, molecular docking, antidiabetic(in vitro & in vivo) DNA and BSA interaction studies of ruthenium(II) carboxylate complexes
  5. Heteroleptic tri- and di-organotin(IV) carboxylates: Synthesis, characterization and anticancer evaluation
  6. Synthesis, spectral, in silico/molecular docking and pharmacological studies of biologically potent triorganotin(IV) carboxylates
  7. Sustainable biodiesel production via castor oil transesterification using organotin(IV) compounds as catalysts
  8. Synthesis, characterization, exploration of anti-cancer, anti-leishmanial, anti-microbial activities, pharmacokinetic and docking studies of Sn(IV) complexes
  9. Design, physicochemical confirmation, single crystal structures as well as exploration of antibacterial and anticancer potential of organotin(IV) carboxylates
  10. Designing and Exploration of the Biological Potentials of Novel Centrosymmetric Heteroleptic Copper(II) Carboxylates
  11. Synthesis, Physicochemical Characterization, Biological Evaluation, In Silico and Molecular Docking Studies of Pd(II) Complexes with P, S-Donor Ligands
  12. Synthesis, Structural Elucidation and Pharmacological Applications of Cu(II) Heteroleptic Carboxylates
  13. A Broad Spectrum Antiparasitic Activity of Organotin (IV) Derivatives and Its Untargeted Proteomic Profiling Using Leishmania donovani
  14. Three isomeric 4-[(n-bromophenyl)carbamoyl]butanoic acids (n = 2, 3 and 4) as DNA intercalator: Synthesis, physicochemical characterization, antimicrobial activity, antioxidant potential and in silico study
  15. Designing, physiochemical confirmation, evaluation of biological and in-silico potential of Triorganotin(IV) complexes
  16. Synthesis, physicochemical characterization, DNA binding and in silico studies of (E)-4-((2-methoxyphenyl)amino)-4-oxobut-2-enoic acid and its triorganotin complexes
  17. 4-[(2,4-Dichlorophenyl)carbamoyl]butanoic Acid
  18. 4-[(4-Chlorophenyl)carbamoyl]butanoic Acid
  19. Organotin(IV) derivatives based on 2-((2-methoxyphenyl)carbamoyl)benzoic acid: Synthesis, spectroscopic characterization, assessment of antibacterial, DNA interaction, anticancer and antileishmanial potentials
  20. Designing, spectroscopic and structural characterization and evaluation of biological potential as well as molecular docking studies of Zn(II)-based metallo-pharmaceuticals
  21. DNA Interaction and Biological Activities of Heteroleptic Palladium (II) Complexes
  22. Crystal structure of 4-[(2-methoxyphenyl)carbamoyl]butanoic acid, C12H15NO4
  23. Crystal structure of 4-[(3,5-dichlorophenyl)carbamoyl]butanoic acid, C11H11Cl2NO3
  24. Crystal structure of 4-[(3-methoxyphenyl)carbamoyl]butanoic acid, C12H15NO4
  25. Crystal structure of 4-[(4-methoxy-2-nitrophenyl)carbamoyl]butanoic acid, C12H14N2O6
  26. Influence of W-doping on the optical and electrical properties of SnO2 towards photocatalytic detoxification and electrocatalytic water splitting
  27. Exploration of biological potency of carboxylic acid derivatives: Designing, synthesis, characterizations and molecular docking study
  28. Synthesis, characterization and biological screenings of 5-coordinated Organotin(IV) complexes based on carboxylate ligand
  29. Synthesis, structural peculiarities, theoretical study and biological evaluation of newly designed O-Vanillin based azomethines
  30. New tri- and di-alkylstannyl 2-(1H-indol-3-yl)ethanoates: synthesis, characterization and biological screenings
  31. 2-Phenylbutyric acid based organotin(IV) carboxylates; synthesis, spectroscopic characterization, antibacterial action against plant pathogens and in vitro hemolysis
  32. Zinc metal carboxylates as potential anti-Alzheimer’s candidate: in vitro anticholinesterase, antioxidant and molecular docking studies
  33. Synthesis, characterization crystal structures and DNA binding studies of zinc complexes with oxygen and nitrogen donor ligands
  34. Organotin (IV) Complexes as Catalyst for Biodiesel Formation: Synthesis, Structural Elucidation and Computational Studies
  35. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates
  36. Exploration of organotin(IV) derivatives for medicinal applications: Synthesis, spectroscopic characterization, structural elucidation and molecular docking study
  37. Synthesis, characterization, biological screenings and molecular docking study of Organotin(IV) derivatives of 2,4-dichlorophenoxyacetic acid
  38. Synthesis, spectroscopic characterization, crystal structure, interaction with DNA, CTAB as well as evaluation of biological potency, docking and Molecular Dynamics studies of N-(3,4,5-trimethoxybenzylidene)-2, 3-dimethylbenzenamine
  39. Exploration of Antioxidant Activities of Potentially Bioactive Compounds in Trianthema portulacastrum Herb: Chemical Identification and Quantification by GC‐MS and HPLC
  40. Designing of homo and heteroleptic zinc(II) carboxylates: synthesis, spectroscopic characterizations, DNA binding study, CTAB interaction and in vitro antimicrobial evaluations
  41. Synthesis, physicochemical characterizations and in vitro biological evaluations of amide based Zn(II) carboxylates
  42. Synthesis, Characterization, DNA Interaction Study, Antibacterial and Anticancer Activities of New Palladium(II) Phosphine Complexes
  43. Organotin(IV) 4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazine-1-carbodithioates: Synthesis, characterization and biological activities
  44. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations
  45. Synthesis, Spectral Characterization, In Vitro Antibacterial Evaluation and POM Analyses of Palladium(II) Thiocyanate Complexes of Thioamides
  46. Biological evaluations and spectroscopic characterizations of 3-(4-ethoxyphenyl)-2-methylacrylate based organotin(IV) carboxylates derivatives
  47. Synthesis, structural characterization and biological screening of heteroleptic palladium(II) complexes
  48. Synthesis, biological investigation, calf thymus DNA binding and docking studies of the sulfonyl hydrazides and their derivatives
  49. Pharmacological investigation of mono-, di- and tri-organotin(IV) derivatives of carbodithioates: Design, spectroscopic characterization, interaction with SS-DNA and POM analyses
  50. Stannic chloride-para toluene sulfonic acid as a novel catalyst-co-catalyst system for the designing of hydroxyl terminated polyepichlorohydrin polymer: Synthesis and characterization
  51. Corrigendum to “Design, structural and spectroscopic elucidation and in vitro antimicrobial, anticancer, antileishmanial, urease inhibition activities and interaction with SS-DNA of newly synthesized amide based carboxylic acid” [Inorg. Chim. Acta 427 ...
  52. Synthesis, spectroscopic characterization, biological screenings, DNA binding study and POM analyses of transition metal carboxylates
  53. Design, structural and spectroscopic elucidation and in vitro antimicrobial, anticancer, antileishmanial, urease inhibition activities and interaction with SS-DNA of newly synthesized amide based carboxylic acid
  54. Synthesis, spectroscopic characterization and in vitro antimicrobial, anticancer and antileishmanial activities as well interaction with Salmon sperm DNA of newly synthesized carboxylic acid derivative, 4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid
  55. Synthesis, spectroscopic characterization, crystal structure, DNA interaction study and in vitro biological screenings of 4-(5-chloro-2-hydroxyphenylamino)-4-oxobut-2-enoic acid
  56. Organotin(IV) complexes of carboxylate derivative as potential chemotherapeutic agents against Leishmania
  57. Potentially bioactive organotin(IV) compounds: Synthesis, characterization, in vitro bioactivities and interaction with SS-DNA
  58. Biological screening, DNA interaction studies, and catalytic activity of organotin(IV) 2-(4-ethylbenzylidene) butanoic acid derivatives: synthesis, spectroscopic characterization, and X-ray structure
  59. Synthesis, spectroscopic characterization, pH dependent redox mechanism and DNA binding behavior of chlorohydroxyaniline derivatives
  60. Organotin(iv) carboxylate derivatives as a new addition to anticancer and antileishmanial agents: design, physicochemical characterization and interaction with Salmon sperm DNA
  61. Potential bioactive Schiff base compounds: Synthesis, characterization, X-ray structures, biological screenings and interaction with Salmon sperm DNA
  62. Triphenyl(pyrrolidine-1-carbodithioato-κS)tin(IV)
  63. 1-(4-Methoxyphenyl)pyrrolidine-2,5-dione
  64. Potential bioactive Vanillin–Schiff base di- and tri-organotin(IV) complexes of 4-((3,5-dimethylphenylimino)methyl)-2-methoxyphenol: synthesis, characterization and biological screenings
  65. Drug–DNA interactions and their study by UV–Visible, fluorescence spectroscopies and cyclic voltametry
  66. Synthesis, spectroscopic characterization, X-ray structure and biological screenings of organotin(IV) 3-[(3,5-dichlorophenylamido)]propanoates
  67. Synthesis, spectroscopic characterization, X-ray structures, biological screenings, DNA interaction study and catalytic activity of organotin(IV) 3-(4-flourophenyl)-2-methylacrylic acid derivatives
  68. Synthesis, characterization, biological screenings and interaction with calf thymus DNA of a novel azomethine 3-((3,5-dimethylphenylimino)methyl)benzene-1,2-diol
  69. 2-(2-Methoxyphenyl)-1H-isoindole-1,3(2H)-dione
  70. 1-(2-Methoxyphenyl)-1H-pyrrole-2,5-dione
  71. Synthesis, characterization, biological screenings and interaction with calf thymus DNA as well as electrochemical studies of adducts formed by azomethine [2-((3,5-dimethylphenylimino)methyl)phenol] and organotin(IV) chlorides